English
Back
Open Account

Shengnuo Pharmaceuticals 2022 Annual Results Investor Presentation

Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty. Read more
1
2
+0
See Original
Report
18K Views
Comment
Sign in to view/post comments
avatar
SIRNAOMICS
The official account of Sirnaomics Ltd
Sirnaomics (Sirnaomics) is the first clinical grade RNA therapy biopharmaceutical company with an important market position in both China and the US.
18K
Followers
13K
Visitors
Follow
Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Trump cheers on towards 100,000! Will the Dow continue its surge after breaking through 50,000 point
On February 10 Eastern Time, the Dow Jones Industrial Average hit another all-time high! Previously, on February 6, the Dow surpassed the hi Show More